ENTA  valuation analysis

Basics
Name: Enanta Pharmaceuticals Inc
Description: Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 09, 2022
Market cap: $795.73M (1277th)
Sales(TTM): $91.56M (1400th)
Earnings(TTM): -$112.33M (1354th)

Value
FFER: 1.01 (why)
Actual price: $38.72
FFEThis is Enanta Pharmaceuticals Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $38.20
Quantile: ENTA is expensive given its fundamentals.
Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Enanta Pharmaceuticals Inc
"Biotechnology" industry
Sales / MarketCap
Enanta Pharmaceuticals Inc
"Biotechnology" industry
Book / MarketCap
Enanta Pharmaceuticals Inc
"Biotechnology" industry
Equity / Assets
Enanta Pharmaceuticals Inc
"Biotechnology" industry